Rick Booth Chief Financial Officer Scott Oberlink Chief Technology Officer Matt Ruderman Chief Legal Officer Craig Hazenfield Chief People Officer Bill Moschella GM, Provider & Life Sciences Claims Cautionary statement regarding forward-looking statements References in this presentation to profitability are on an Adjusted EBITDA basis. 3 Category-defining software platform for healthcare commercial intelligence and analytics | --- | --- ...

Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman and Interim Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jared Haase - William Blair Matt Shea - Needham & Company Anne Samuel - JPMorgan David Grossman - Stifel Stephanie Davis - Barclays Operator Welcome to Definitive Healthcare’s Q1 ...

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post earnings of $0.07 per share when it actually produced earnings of $0.07, delivering no surprise.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Definitive Healthcare, which b ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other jur ...

Recent Business and Operating Highlights: Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: "While our first quarter ...

FRAMINGHAM, Mass. and LONDON, March 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH) and VML Health announced a first-of-its-kind partnership that gives clients the ability to manage their entire key opinion leader (KOL) identification and engagement operation from an integrated solution. This partnership provides an answer to the increasingly complex challenges that the health industry faces when identifying and engaging with the most relevant KOLs at a global level. The new solution has been ...

FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business Journal's Middle Market Leaders for 2024, a ranking of the 50 highest growth companies in Massachusetts. This marks the second year in a row that Definitive Healthcare has won this award. The Boston Business Journal selects the Middle Market Leaders using a weighted index score based on revenue gr ...

Cautionary statement regarding forward-looking statements | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Jason Krantz - Founder and Executive Chairman and Interim CEO Richard Booth - CFO Conference Call Participants Stephanie Davis - Barclays Craig Hettenbach - Morgan Stanley Craig Jones - Stifel Matthew Shea - Needham & Company Allen Lutz - Bank of America Jared Haase - William Blair Johnathan McCary - Raymond James George Hill - Deutsche Bank Operator ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of Registrant as specified in its Charter) Delaware 86-3988281 (State or other jurisdic ...